The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes ...

The president of the European Union’s executive branch, Ursula von der Leyen, faces a no-confidence vote this week linked in ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...

Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.

In spite of its sustainable moat, Palantir Technologies is butting heads with historical headwinds that have a flawless track ...

Pfizer Inc. (NYSE: PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...